4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-23-012996
Chief Medical Officer sold 2,878 shares at $25.97 ($74,750)
- Chief Medical Officer acquired 60,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pang Phillip Chief Medical Officer | 2023-02-22 | Grant or award | +60,000 | 201,198 | D | ||
| Pang Phillip Chief Medical Officer | 2023-02-23 | Sale | −2,878 | $25.97 | $74,750 | 198,320 | D |
| Derivatives | |||||||
| Pang Phillip Chief Medical Officer | 2023-02-22 | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | D | ||
| Open-market sales · 2,878 sh · avg $25.97 · $74,750 | |||||||
Loading xslF345X03/doc4.xml…